October, 2016|0 Comments
PharmaMar and Boryung Pharm sign a licensing agreement for Aplidin® (plitidepsin) in Korea.
Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience.
Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for […]
TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson […]
September, 2016|0 Comments
4SC sells immunology portfolio to Immunic
July, 2016|0 Comments
LEO Pharma enters biologics through strategic partnership with AstraZeneca.
June, 2016|0 Comments
AFFiRiS AG successfully raises €10m equity financing
Targovax and Oncos Therapeutics join forces to create a Nordic leader within immuno-oncology.
May, 2016|0 Comments
4SC enters into licensing and development partnership with Link Health for the cancer compound 4SC 205 in China.
February, 2016|0 Comments
PharmaMar and Specialised Therapeutics Asia sign licensing and marketing agreement for APLIDIN® (plitidepsin) covering several Asian countries.
January, 2016|0 Comments
Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology.
December, 2015|0 Comments
Bavarian Nordic Enters Licensing and Collaboration Agreement with Janssen for MVA-BN® in the Development of a Therapeutic HPV Vaccine.
November, 2015|0 Comments
LEO Pharma to acquire global dermatology portfolio from Astellas.
ObsEva and Kissei Pharmaceutical Announce Global Agreement to Develop and Commercialize KLH-2109 for the Treatment of Endometriosis.
Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes.
October, 2015|0 Comments
Nuevolution Announces Drug Discovery Collaboration with Johnson & Johnson Innovation.
August, 2015|0 Comments
PharmaMar announces license agreement with Specialised Therapeutics Australia Pty for APLIDIN® (plitidepsin) in oncology.
Inovio Pharmaceuticals enters into Strategic Cancer Vaccine Collaboration and License Agreement with MedImmune
July, 2015|0 Comments
PharmaMar announces license agreement with TTY Biopharm for APLIDIN® (plitidepsin) in hematological cancers
June, 2015|0 Comments
LEO Pharma Enters Supply and Distribution Agreement with NeoPharm on Non-Prescription Skin Care Solutions
May, 2015|0 Comments
arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions
April, 2015|0 Comments
HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction
4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan
Medivir and Cancer Research Technology collaborate to develop new class of cancer drugs
Immunocore and MedImmune enter immunotherapy agreement to develop novel cancer therapies
Bristol-Myers Squibb and uniQure Enter into Exclusive Strategic Collaboration to Develop Gene Therapies for Cardiovascular Diseases
March, 2015|0 Comments
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC®, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy
January, 2015|0 Comments
Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and […]
November, 2014|0 Comments
Lexicon And Ipsen Enter Into Ex-North America/Japan Licensing And Commercialization Agreement For Telotristat Etiprate
Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program
LEO Pharma and Japan Tobacco Enter into License Agreement for Novel JAK inhibitor Drug Candidate
October, 2014|0 Comments
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine
September, 2014|0 Comments
Distribution, License & Supply Agreement Announced with Medical Developments International
August, 2014|0 Comments
Allergan Acquires LiRIS®Program from TARIS Biomedical®
uniQure Acquires Cardiology Gene Therapy Company InoCard
Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim
July, 2014|0 Comments
Zealand and Boehringer Ingelheim sign second collaboration agreement to advance novel peptide medicines
LEO Pharma & KLOX Technologies strike global dermatology deal
PharmaMar and Chugai Pharma Marketing Enter into a License and Commercialization Agreement in Europe for Aplidin®
PharmaMar signs licence agreement with GP Pharm to market Politrate® in Italy for treating prostate cancer
June, 2014|0 Comments
Immunocore and Lilly Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies
March, 2014|0 Comments
Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology
February, 2014|0 Comments
Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718
September, 2013|0 Comments
Roche and Inovio Pharmaceuticals partner on Inovio’s prostate cancer and hepatitis B immunotherapy products
June, 2013|0 Comments
Novavax Announces Public Offer for All Outstanding Shares of Isconova
February, 2013|0 Comments
4SC Discovery and LEO Pharma announce exclusive research and license agreement for inflammatory skin diseases